Pages that link to "Q36492148"

The following pages link to Monitoring therapeutic efficacy in breast carcinomas (Q36492148):

Displaying 23 items.

• Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment (Q33996547) (← links)
• Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy (Q34050338) (← links)
• A semantic image annotation model to enable integrative translational research (Q34585138) (← links)
• Imaging and cancer: a review (Q34977050) (← links)
• Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer (Q35657487) (← links)
• Diffuse optical imaging using spatially and temporally modulated light (Q36714281) (← links)
• Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007. (Q37309198) (← links)
• Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors (Q37446412) (← links)
• Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI). (Q37671891) (← links)
• Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit (Q37800802) (← links)
• Best Practices: Consensus on Performing Positron Emission Tomography-Computed Tomography for Radiation Therapy Planning and for Therapy Response Assessment (Q37819377) (← links)
• Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer? (Q38000076) (← links)
• A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints (Q38015026) (← links)
• Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. (Q38059133) (← links)
• Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer (Q40852747) (← links)
• Breast MRI: guidelines from the European Society of Breast Imaging. (Q43066187) (← links)
• Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging (Q43150626) (← links)
• Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study (Q47155897) (← links)
• MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy (Q47372160) (← links)
• A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features. (Q47766584) (← links)
• Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype. (Q55003756) (← links)
• MRI evaluation of residual breast carcinoma after neoadjuvant chemotherapy (Q84971472) (← links)
• Breast Tumor Detection and Classification Using Intravoxel Incoherent Motion Hyperspectral Imaging Techniques (Q92999719) (← links)